Mon. Jul 4th, 2022
Metastatic Castration-Sensitive Prostate Cancer Market

DelveInsight’s “Adult Growth Hormone Deficiency (AGHD) Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology as well as the Adult Growth Hormone Deficiency market trends in the seven major markets (7MM) (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The report also covers provides insights into the emerging drugs, current treatment practices, market share of the individual therapies, market drivers, barriers, unmet medical needs, current and forecasted market size from 2019 to 2032 segmented by 7MM. 

Adult Growth Hormone Deficiency Disease Overview

Adult-Onset Growth Hormone Deficiency (AGHD) is a medical condition that occurs when the body does not produce enough growth hormone. It stimulates the release of another hormone called insulin-like growth factor 1, which is produced mainly by the liver. Together, these hormones produce growth in childhood and, in adult life, have widespread metabolic effects throughout the body.

Adults with GHD fall into two categories which include: childhood-onset (GHD began during childhood and has continued) and Adult-onset (GHD developed after reaching adulthood). GHD in adults is associated with premature mortality, increased adiposity or fat mass, as well as psychiatric-cognitive, cardiovascular, muscular, metabolic, and skeletal abnormalities.

Adult Growth Hormone Deficiency Market Key Facts

  • According to D B Allen et al., about 15%-20% of the cases represent the transition of childhood GH deficiency into adulthood.
  • As per Jana Bujanova et al., the estimated prevalence of AGHD in the UK is approximately 1 in 10 000 (a total of approximately 6380 patients). If Childhood-onset GH deficiency is added to this number then prevalence is 1 in 10 000 to 1 in 3500.
  • According to Growth hormone Foundation estimates, more than 50,000 adults in the United States are growth hormone deficient, and 6,000 new cases are reported each year, including GHD children who transition to GHD as an adult.
  • According to the study conducted by Akira Shimatsu et al., a greater proportion (80%) of Japanese adults had adult-onset GHD than childhood-onset GHD.

Adult Growth Hormone Deficiency Market

Adult Growth Hormone Deficiency (AGHD) market size is expected to increase during the forecast period owing to the Extensive R&D activities by academics and companies and the rise in the number of Prevalent cases of Adult growth hormone deficiency patients in 7MM.

The market outlook section of the report helps to understand the historic, current, and forecasted Adult Growth Hormone Deficiency market size by analyzing the impact of current therapies on the market, unmet needs, and demand for better technology. 

The report gives a thorough detail of key trends, ongoing developments, and growth opportunities of each marketed and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, mechanism of action, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders in the domain. 

Get the PDF Sample of the Report @ https://www.delveinsight.com/sample-request/adult-growth-hormone-deficiency-aghd-market

Adult Growth Hormone Deficiency Epidemiology

The epidemiology section covers insights into the historical and current Adult Growth Hormone Deficiency patient pool and forecasted trends for every seven major markets from 2019 to 2032. 

It helps to recognize the causes of current and forecasted epidemiology trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.  

Discover more about the epidemiological segmentation @ https://www.delveinsight.com/sample-request/adult-growth-hormone-deficiency-aghd-market

Adult Growth Hormone Deficiency Drugs Uptake and Key Market Players

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Adult Growth Hormone Deficiency market or expected to get launched in the market during the study period. The analysis covers the drug uptake; patient uptake by therapies; and sales of each drug.   

Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The report also covers the Adult Growth Hormone Deficiency Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II, and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses the recent development such as collaborations, acquisitions, and mergers, licensing patent details, and other information.

Adult Growth Hormone Deficiency Therapeutics Analysis

The Adult growth hormone deficiency market dynamics is anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, incremental healthcare spending across the world & the launch of emerging therapies during the forecast period. 

Some of the key companies in the Adult Growth Hormone Deficiency (AGHD) Market include:

  • Ascendis Pharma
  • Genexine
  • OPKO Health
  • Novo Nordisk

And many others.

Adult Growth Hormone Deficiency (AGHD) therapies covered in the report include:

  • TransCon hGH
  • HyTropin
  • Somatrogon
  • Norditropin

And many more.

Get More Detailed Insights into the Emerging Therapies & Key Companies:- https://www.delveinsight.com/sample-request/adult-growth-hormone-deficiency-aghd-market

Table of Content

  1. Key Insights
  2. Executive Summary 
  3. Adult Growth Hormone Deficiency Competitive Intelligence Analysis
  4. Adult Growth Hormone Deficiency Market Overview at a Glance
  5. Adult Growth Hormone Deficiency Disease Background and Overview
  6. Adult Growth Hormone Deficiency Patient Journey
  7. Adult Growth Hormone Deficiency Epidemiology and Patient Population
  8. Adult Growth Hormone Deficiency Treatment Algorithm, Current Treatment, and Medical Practices
  9. Adult Growth Hormone Deficiency Unmet Needs
  10. Key Endpoints of Adult Growth Hormone Deficiency Treatment
  11. Adult Growth Hormone Deficiency Marketed Products
  12. Adult Growth Hormone Deficiency Emerging Therapies
  13. Adult Growth Hormone Deficiency Seven Major Market Analysis
  14. Attribute Analysis
  15. Adult Growth Hormone Deficiency Market Outlook (7 major markets)
  16. Adult Growth Hormone Deficiency Access and Reimbursement Overview
  17. KOL Views on the Adult Growth Hormone Deficiency Market.
  18. Adult Growth Hormone Deficiency Market Drivers
  19. Adult Growth Hormone Deficiency Market Barriers
  20. Appendix
  21. DelveInsight Capabilities
  22. Disclaimer

*The table of contents is not exhaustive; the final content may vary. 

Request Sample Report here:- https://www.delveinsight.com/sample-request/adult-growth-hormone-deficiency-aghd-market

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance. 

Contact Info:
Shruti Thakur
Assistant Manager, Marketing & IB
Phone No: +91-9650213330
Email: [email protected]
Website: https://www.delveinsight.com/
Connect With Us: LinkedIn | Facebook | Twitter
For Latest Update: Healthcare Blog
Request for Sample Copy of the Report at:
https://www.delveinsight.com/sample-request/adult-growth-hormone-deficiency-aghd-market

 

Latest Reports By DelveInsight:

Adult Growth Hormone Deficiency (AGHD) Epidemiology Forecast

“Adult Growth Hormone Deficiency (AGHD) Epidemiology Forecast” report delivers an in-depth understanding of the disease, historical, and forecasted epidemiology of Adult Growth Hormone Deficiency (AGHD) in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

Adult Growth Hormone Deficiency (AGHD) Pipeline Insights

“Adult Growth Hormone Deficiency (AGHD) Pipeline Insights” report by DelveInsight outlays comprehensive insights into the present clinical development scenario and growth prospects across the Adult Growth Hormone Deficiency (AGHD) market.

Mucinous Cystic Neoplasms (MCNs) Market

“Mucinous cystic neoplasms (MCNs) Market” research report delivers an in-depth understanding of the historical and forecasted epidemiology, Mucinous Cystic Neoplasms Market Trends in 7MM as well as the key companies and emerging therapies in the therapeutics market.

Secondary Hyperparathyroidism Market

“Secondary Hyperparathyroidism Market” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology as well as the market size, share, trends, and ongoing developments in 7MM.

Tenosynovitis Market

“Tenosynovitis Market” report delivers an in-depth understanding of the Tenosynovitis, historical and forecasted epidemiology as well as the Tenosynovitis market trends in 7MM.

Bevacizumab Biosimilars Insight

“Bevacizumab Biosimilar Insight” report provides comprehensive insights about 40+ companies and 40+ marketed and pipeline drugs in the Bevacizumab Biosimilars landscape. The report also covers the marketed and pipeline drug profiles, including clinical and non-clinical stage products.

Herpes Simplex Virus Market

“Herpes Simplex Virus Market” report provides a detailed overview of the disease and an in-depth understanding of historical and forecasted epidemiology as well as the Herpes Simplex Virus market size, share, trends, and forecast in the 7MM.

Dense Deposit Disease Market

“Dense Deposit Disease Market” report delivers an in-depth understanding of the Dense Deposit Disease, historical and forecasted epidemiology as well as the Dense Deposit Disease market trends in 7MM.

Myasthenia Gravis Market

“Myasthenia Gravis Market” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Myasthenia Gravis market trends in 7MM.

Preeclampsia Market

“Preeclampsia Market” report delivers an in-depth understanding of Preeclampsia, historical and forecasted epidemiology as well as the Preeclampsia market trends, emerging therapies, and key companies operating in the domain.

By krehani

Leave a Reply

Your email address will not be published. Required fields are marked *